Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
Gluten Free Diet for GVHD Prophylaxis
Sponsor: National Cancer Institute (NCI)
Terminated
Slow accrual
Other terminated trials from National Cancer Institute (NCI)
Other Graft Versus Host Disease trials with similar outcome
This NA trial investigates Graft Versus Host Disease and Hematopoietic Cell Transplantation Recipient and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Sep 2021 [monthly]
Terminated NA
-
Jul 2019 — Jan 2021 [monthly]
Terminated NA
Status: Completed → Terminated
▶ Show 4 earlier versions
-
Sep 2018 — Jul 2019 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Rutgers, The State University of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .